Two Sigma Advisers’s Collegium Pharmaceutical COLL Stock Holding History

Two Sigma Advisers’s Portfolio COLL Stock Details COLL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$639K	Sell	21,600 -24,700	-53%	-$730K	﹤0.01%	1640
2025 Q1	$1.38M	Sell	46,300 -25,700	-36%	-$767K	﹤0.01%	1310
2024 Q4	$2.06M	Sell	72,000 -145,300	-67%	-$4.16M	﹤0.01%	1110
2024 Q3	$8.4M	Sell	217,300 -40,600	-16%	-$1.57M	0.02%	534
2024 Q2	$8.3M	Sell	257,900 -9,800	-4%	-$316K	0.02%	594
2024 Q1	$10.4M	Buy	267,700 +22,700	+9%	+$881K	0.02%	530
2023 Q4	$7.54M	Sell	245,000 -64,000	-21%	-$1.97M	0.02%	648
2023 Q3	$6.91M	Sell	309,000 -600	-0.2%	-$13.4K	0.02%	595
2023 Q2	$6.65M	Buy	309,600 +132,600	+75%	+$2.85M	0.02%	639
2023 Q1	$4.25M	Buy	177,000 +134,500	+316%	+$3.23M	0.01%	873
2022 Q4	$986K	Buy	42,500 +29,300	+222%	+$680K	﹤0.01%	1572
2022 Q3	$211K	Buy	+13,200	New	+$211K	﹤0.01%	2183
2022 Q2	–	Sell	-26,700	Closed	-$544K	–	2690
2022 Q1	$544K	Buy	26,700 +5,000	+23%	+$102K	﹤0.01%	1944
2021 Q4	$405K	Sell	21,700 -7,900	-27%	-$147K	﹤0.01%	2014
2021 Q3	$584K	Sell	29,600 -27,100	-48%	-$535K	﹤0.01%	1861
2021 Q2	$1.34M	Sell	56,700 -28,800	-34%	-$681K	﹤0.01%	1505
2021 Q1	$2.03M	Buy	+85,500	New	+$2.03M	0.01%	1262
2020 Q4	–	Sell	-46,100	Closed	-$960K	–	2420
2020 Q3	$960K	Sell	46,100 -64,600	-58%	-$1.35M	﹤0.01%	1515
2020 Q2	$1.94M	Buy	110,700 +30,500	+38%	+$534K	0.01%	1218
2020 Q1	$1.31M	Buy	80,200 +57,500	+253%	+$939K	0.01%	1332
2019 Q4	$467K	Buy	+22,700	New	+$467K	﹤0.01%	1903
2019 Q3	–	Sell	-29,000	Closed	-$381K	–	2250
2019 Q2	$381K	Buy	29,000 +1,900	+7%	+$25K	﹤0.01%	1918
2019 Q1	$410K	Buy	27,100 +4,300	+19%	+$65.1K	﹤0.01%	1865
2018 Q4	$391K	Sell	22,800 -8,200	-26%	-$141K	﹤0.01%	1869
2018 Q3	$457K	Buy	31,000 +16,000	+107%	+$236K	﹤0.01%	1828
2018 Q2	$358K	Buy	+15,000	New	+$358K	﹤0.01%	2042